Chester County News and Community Website
BLUE BELL, PA — Unisys Corporation (NYSE: UIS), a global information technology company, recently released its financial figures for the first quarter of 2024, revealing a complex landscape of growth …
Unisys Reports Mixed First Quarter Results Amid Transformation Efforts Read More
NEWTOWN, PA — Helius Medical Technologies, Inc. (NASDAQ: HSDT) is set to announce its financial outcomes for the first quarter of 2024 on Monday, May 13, after the market closure.
Helius Medical Technologies to Unveil Q1 2024 Results and Discuss PoNS® U.S. Commercialization Read More
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) recently disclosed its first-quarter financial results for 2024, showcasing significant growth and strategic advancements. The company reported a revenue of $16.6 million, …
TELA Bio Reports Strong First Quarter Growth, Expands Product Portfolio Read More
WILMINGTON, DE — Acorn Energy, Inc. (OTCQB: ACFN) recently unveiled its first quarter results for 2024, sparking a renewed surge of interest and excitement among investors as they analyze the …
Acorn Energy Shows Promising Growth and Solid Future: An In-depth Analysis Read More
PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC), a pioneer in developing induced pluripotent stem cell (iPSC) derived therapies, shared a promising update on its financial standing and strategic advancements …
Century Therapeutics Announces Expansion and Significant Progress in Autoimmune and Cancer Therapies Read More
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a leading biopharmaceutical company, this week announced its impressive financial results and corporate developments for the first quarter ending March 31, 2024.
Mineralys Therapeutics Reports Robust Financial Results for Q1 2024 Read More
BALA CYNWYD, PA — Larimar Therapeutics (Nasdaq: LRMR) recently unveiled its Q1 2024 operational and financial results. The biopharmaceutical company is making remarkable progress in the clinical program of their …
Larimar Therapeutics’ Promising Q1 2024 Results Show Potential Treatment for Friedreich’s Ataxia Read More
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX), a pioneering biopharmaceutical company, unveiled its first-quarter financial results for 2024, spotlighting not only solid fiscal performance but also significant strides in …
Context Therapeutics Posts Strong Q1 Financials, Advances Key Cancer Drug Trials Read More
NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. (Nasdaq: AVBP) has announced positive strides in its first-quarter progress, particularly in the development of firmonertinib, a promising drug for non-small cell lung …
ArriVent BioPharma Advances in Lung Cancer Research, Sets Sights on Future Milestones Read More
MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH), a global manufacturer and supplier of semiconductors and passive components, disclosed its fiscal first quarter results, revealing a mix of challenges and …
Vishay Intertechnology Reports First Quarter Results, Eyes Recovery in H2 2024 Read More